Laurus stock funds renewable investment as earnings stay strong

Published on 10/07/2026 at 05:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Laurus stock was at INR 2,047 on October 7, 2026, while Q1 FY27 revenue rose 29 percent to INR 2,026 crore. Net profit climbed 126 percent to INR 368 crore.

Laurus, INE947Q01028, Illustration mit AI erstellt.

Laurus Labs (ISIN INE947Q01028) was last at INR 2,047 on the NSE on October 7, 2026 at 9:21 a.m. IST, down 0.15 percent from the prior close. The latest corporate action adds a renewable-energy angle to the pharmaceutical company's growth story.

Renewable stake stays at 26 percent

According to ScanXNews on October 6, 2026, Laurus Labs invested INR 12.09 crore in Kurnool Renewables Private Limited through a rights issue. The company acquired 1.21 crore shares at a face value of INR 10 each, lifting its total holding to 2.12 crore shares while keeping its ownership at 26 percent.

The unchanged percentage matters because the transaction preserves Laurus Labs' existing position in its associate rather than creating a new control structure. The investment also links the company to captive renewable power capacity, adding an operating-efficiency element to a capital-intensive expansion plan.

Q1 earnings show operating leverage

The most recent reported quarter was Q1 FY27. ScanXNews reported on September 18, 2026 that revenue increased 29 percent year over year to INR 2,026 crore, while net profit rose 126 percent to INR 368 crore.

EBITDA reached INR 644 crore in Q1 FY27, up 66 percent year over year, and the EBITDA margin expanded to 31.8 percent from 24.8 percent. The combination of revenue growth and a 7.0 percentage-point margin gain shows why investors are placing greater weight on the CDMO business and the company's capacity investments.

Capital expenditure reached INR 394 crore in the quarter, equal to 19 percent of sales, while research and development spending rose 74 percent to INR 118 crore. That spending profile creates a clear trade-off: stronger capacity and product capabilities require substantial cash deployment before all new projects contribute to revenue.

Stock trades near its yearly high

Laurus stock's October 7 intraday range was INR 2,046.80 to INR 2,063.40, with volume at 98,269 shares. Its 52-week range was INR 843 to INR 2,063.40, placing the latest price INR 16.40 below the high, or 0.79 percent.

The market capitalization stood at INR 1,105.9 billion as of October 7, 2026. For investors, the central measure is whether the 31.8 percent Q1 EBITDA margin can coexist with the INR 394 crore quarterly investment rate as Laurus Labs expands its CDMO and biologics capabilities.

INR 2,047 remains the reference level

Laurus stock was last at INR 2,047 on the NSE on October 7, 2026 at 9:21 a.m. IST, with the daily change at negative 0.15 percent. The quotation remains close to the 52-week high while the latest earnings figures and the renewable investment provide the main company-specific measures for assessing the shares.